2008
DOI: 10.1016/j.cgh.2007.12.044
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Eradication of Helicobacter pylori on the Histology and Cellular Phenotype of Gastric Intestinal Metaplasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
54
2
1

Year Published

2008
2008
2024
2024

Publication Types

Select...
5
1
1

Relationship

3
4

Authors

Journals

citations
Cited by 38 publications
(68 citation statements)
references
References 57 publications
9
54
2
1
Order By: Relevance
“…The underlying mechanism of the reversal of those molecular events after H. pylori treatment remains elusive. According to the findings of previous reports, it is well known that GIN, a promoter methylation and Das-1 reactivity is associated with chronic inflammatory conditions in gastrointestinal diseases such as BE, 44 chronic gastritis 29,31 and inflammatory bowel disease. 45 The decrease in inflammation in the stomach after the cure of the bacteria may be related to these changes, but it may be difficult to clarify those mechanisms in the current study.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The underlying mechanism of the reversal of those molecular events after H. pylori treatment remains elusive. According to the findings of previous reports, it is well known that GIN, a promoter methylation and Das-1 reactivity is associated with chronic inflammatory conditions in gastrointestinal diseases such as BE, 44 chronic gastritis 29,31 and inflammatory bowel disease. 45 The decrease in inflammation in the stomach after the cure of the bacteria may be related to these changes, but it may be difficult to clarify those mechanisms in the current study.…”
Section: Discussionmentioning
confidence: 99%
“…[22][23][24] We, therefore, hypothesized that if H. pylori infection is an important cause of genetic or epigenetic events in BE, then H. pylori eradication may reverse those molecular alterations, thereby halting BE carcinogenesis as well as gastric carcinogenesis. In this study, we evaluated the chronology of genetic, epigenetic events and cellular phenotype, as identified by a monoclonal antibody (mAb) Das-1 (formerly known as 7E 12 H 12 , IgM isotype), which specifically reacts with BE and EAC 25,26 and is strongly associated with small intestinal adenocarcinoma and gastric carcinoma, [27][28][29] in SIM during BE pathogenesis in Japanese individuals with a high rate of H. pylori infection. The effects of the eradication of H. pylori on those molecular alterations and cellular phenotype in SIM were also assessed in a prospective study.…”
mentioning
confidence: 99%
“…Correa et al have proposed that there is a progression from normal gastric mucosa to carcinoma in high risk populations (29). The initial change is early onset superficial gastritis which, although reversible, is triggered by a variety of agents.…”
Section: Chronic Atrophic Gastritismentioning
confidence: 99%
“…Indeed, we recently found that cell kinetics and genetic alterations, i.e. microsatellite instability and K-ras mutations in GIM, play a role in the early events leading to gastric carcinogenesis, and H. pylori eradication settled these genetic events during only the onewww.intechopen.com year post-treatment period (Tanaka et al 2006;Watari et al 2008). Thus, we believe that the follow-up period, up to 4 yrs in this study, is enough to investigate the changes in cellular phenotype and neoplastic biomarkers related to carcinogenesis after H. pylori eradication.…”
Section: Study 1 I N T H I S S T U D Y W E S H O W T H a T H Pylormentioning
confidence: 99%
“…The annual incidence rate of gastric cancer per 100,000 population in various Asian countries, as reported by Parkin et al (Parkin et al, 1997), is very high in the northern parts of Asia, especially in Japan. In this paragraph, we illustrated around our previous studies (Watari et al, 2007;Watari et al, 2008) in the Japanese population, (i) if the eradication of H. pylori affects subsequent (over the course of up to 4 years) histological grade of GIM, (ii) if mAb Das-1 reactivity that identifies colonic phenotype of GIM associated with gastric carcinogenesis changes after eradication of H. pylori, and (iii) to assess the expression of the novel tropomyosin isoform TC22 in GIM before and after H. pylori treatment. p53 expression was also examined, in parallel.…”
Section: Introductionmentioning
confidence: 99%